BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 33516730)

  • 1. Prenatal opioid exposure and vulnerability to future substance use disorders in offspring.
    Abu Y; Roy S
    Exp Neurol; 2021 May; 339():113621. PubMed ID: 33516730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal Opioid Exposure Enhances Responsiveness to Future Drug Reward and Alters Sensitivity to Pain: A Review of Preclinical Models and Contributing Mechanisms.
    Grecco GG; Atwood BK
    eNeuro; 2020; 7(6):. PubMed ID: 33060181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does prenatal methamphetamine exposure induce sensitization to drugs in adulthood?
    Macúchová E; Šlamberová R
    Physiol Res; 2017 Dec; 66(Suppl 4):S457-S467. PubMed ID: 29355373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mid- to late gestational morphine exposure does not alter the rewarding properties of morphine in adult male rats.
    Riley MA; Vathy I
    Neuropharmacology; 2006 Aug; 51(2):295-304. PubMed ID: 16697425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Monoclonal Antibody against 6-Acetylmorphine Protects Female Mice Offspring from Adverse Behavioral Effects Induced by Prenatal Heroin Exposure.
    Kvello AMS; Andersen JM; Øiestad EL; Steinsland S; Aase A; Mørland J; Bogen IL
    J Pharmacol Exp Ther; 2019 Jan; 368(1):106-115. PubMed ID: 30361238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prenatal opioid exposure on synaptic adaptations and behaviors across development.
    Simmons SC; Grecco GG; Atwood BK; Nugent FS
    Neuropharmacology; 2023 Jan; 222():109312. PubMed ID: 36334764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry.
    Grecco GG; Mork BE; Huang JY; Metzger CE; Haggerty DL; Reeves KC; Gao Y; Hoffman H; Katner SN; Masters AR; Morris CW; Newell EA; Engleman EA; Baucum AJ; Kim J; Yamamoto BK; Allen MR; Wu YC; Lu HC; Sheets PL; Atwood BK
    Elife; 2021 Mar; 10():. PubMed ID: 33724184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do prenatally methamphetamine-exposed adult male rats display general predisposition to drug abuse in the conditioned place preference test?
    Šlamberová R; Pometlová M; Schutová B; Hrubá L; Macúchová E; Nová E; Rokyta R
    Physiol Res; 2012; 61(Suppl 2):S129-38. PubMed ID: 23130898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of sensitization to methamphetamine in offspring prenatally exposed to morphine, methadone and buprenorphine.
    Chiang YC; Hung TW; Ho IK
    Addict Biol; 2014 Jul; 19(4):676-86. PubMed ID: 23551991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal L-DOPA exposure produces lasting changes in brain dopamine content, cocaine-induced dopamine release and cocaine conditioned place preference.
    Ren JQ; Jiang Y; Wang Z; McCarthy D; Rajadhyaksha AM; Tropea TF; Kosofsky BE; Bhide PG
    Neuropharmacology; 2011; 60(2-3):295-302. PubMed ID: 20854831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and Motor Outcomes of Children With Prenatal Opioid Exposure: A Systematic Review and Meta-analysis.
    Yeoh SL; Eastwood J; Wright IM; Morton R; Melhuish E; Ward M; Oei JL
    JAMA Netw Open; 2019 Jul; 2(7):e197025. PubMed ID: 31298718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroimaging in infants with prenatal opioid exposure: Current evidence, recent developments and targets for future research.
    Radhakrishnan R; Grecco G; Stolze K; Atwood B; Jennings SG; Lien IZ; Saykin AJ; Sadhasivam S
    J Neuroradiol; 2021 Mar; 48(2):112-120. PubMed ID: 33065196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation by dextromethorphan on the higher liability to morphine-induced reward, caused by prenatal exposure of morphine in rat offspring.
    Wu LY; Chen JF; Tao PL; Huang EY
    J Biomed Sci; 2009 Nov; 16(1):106. PubMed ID: 19930722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mu Opioid Receptor Agonist DAMGO Produces Place Conditioning, Abstinence-induced Withdrawal, and Naltrexone-Dependent Locomotor Activation in Planarians.
    Dziedowiec E; Nayak SU; Gruver KS; Jennings T; Tallarida CS; Rawls SM
    Neuroscience; 2018 Aug; 386():214-222. PubMed ID: 29958944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parental morphine exposure enhances morphine (but not methamphetamine) preference and increases monoamine oxidase-B level in the nucleus accumbens.
    Sadat-Shirazi MS; Karimi F; Kaka G; Ashabi G; Ahmadi I; Akbarabadi A; Toolee H; Vousooghi N; Zarrindast MR
    Behav Pharmacol; 2019 Aug; 30(5):435-445. PubMed ID: 30694818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalamocortical functional connectivity in infants with prenatal opioid exposure correlates with severity of neonatal opioid withdrawal syndrome.
    Radhakrishnan R; Vishnubhotla RV; Guckien Z; Zhao Y; Sokol GM; Haas DM; Sadhasivam S
    Neuroradiology; 2022 Aug; 64(8):1649-1659. PubMed ID: 35410397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who's your daddy? Behavioral and epigenetic consequences of paternal drug exposure.
    Nieto SJ; Kosten TA
    Int J Dev Neurosci; 2019 Nov; 78():109-121. PubMed ID: 31301337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher anhedonia during withdrawal from initial opioid exposure is protective against subsequent opioid self-administration in rats.
    Swain Y; Muelken P; Skansberg A; Lanzdorf D; Haave Z; LeSage MG; Gewirtz JC; Harris AC
    Psychopharmacology (Berl); 2020 Aug; 237(8):2279-2291. PubMed ID: 32388620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in animal models of prenatal opioid exposure.
    Ferrante JR; Blendy JA
    Trends Neurosci; 2024 May; 47(5):367-382. PubMed ID: 38614891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobehavioral Characterization of Perinatal Oxycodone-Exposed Offspring in Early Adolescence.
    Flores A; Nguyen NM; Devanaboyina M; Sanketh S; Athota P; Jagadesan S; Guda C; Yelamanchili SV; Pendyala G
    J Neuroimmune Pharmacol; 2024 Jun; 19(1):29. PubMed ID: 38874861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.